Regulation of Estradiol Synthesis by Aromatase Interacting Partner in Breast (AIPB)

Abstract

Estradiol is essential for the development of female sex characteristics and fertility. Postmenopausal women and breast cancer patients have high estradiol. Aromatase catalyzes estradiol synthesis; however, the factors regulating aromatase activity are unknown. We identified a new 22-kDa protein, aromatase interacting partner in breast (AIPB), from the endoplasmic reticulum of human breast tissue. AIPB expression is reduced in tumorigenic breast and further reduced in triple negative tumors. Like aromatase, AIPB expression is induced by nonsteroidal estrogen. We found that AIPB and aromatase interact in nontumorigenic and tumorigenic breast tissues and cells. Conditional AIPB over expression decreased estradiol and blocking AIPB availability with an AIPB binding antibody increased estradiol in tumorigenic cells. Estradiol synthesis is highly increased in AIPB knockdown cells, suggesting that the newly identified AIPB protein is important for aromatase activity and a key modulator of estradiol synthesis. Thus, a change in AIPB protein expression may represent an early event in tumorigenesis and be predictive of an increased risk of developing breast cancer.